A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

  • Li, Xun (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date29/07/24 → 28/07/29